APA

Hagenbeek A., Carde P., Meerwaldt J. H., Somers R., Thomas J., De Bock R., Raemaekers J. M., van Hoof A., De Wolf-Peeters C. & van Glabbeke M. (19980127). Maintenance of remission with human recombinant interferon alfa-2a in patients with stages III and IV low-grade malignant non-Hodgkin's lymphoma. European Organization for Research and Treatment of Cancer Lymphoma Cooperative Group. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Chicago

Hagenbeek A, Carde P, Meerwaldt J H, Somers R, Thomas J, De Bock R, Raemaekers J M, van Hoof A, De Wolf-Peeters C and van Glabbeke M. 19980127. Maintenance of remission with human recombinant interferon alfa-2a in patients with stages III and IV low-grade malignant non-Hodgkin's lymphoma. European Organization for Research and Treatment of Cancer Lymphoma Cooperative Group. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Harvard

Hagenbeek A., Carde P., Meerwaldt J. H., Somers R., Thomas J., De Bock R., Raemaekers J. M., van Hoof A., De Wolf-Peeters C. and van Glabbeke M. (19980127). Maintenance of remission with human recombinant interferon alfa-2a in patients with stages III and IV low-grade malignant non-Hodgkin's lymphoma. European Organization for Research and Treatment of Cancer Lymphoma Cooperative Group. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

MLA

Hagenbeek A, Carde P, Meerwaldt J H, Somers R, Thomas J, De Bock R, Raemaekers J M, van Hoof A, De Wolf-Peeters C and van Glabbeke M. Maintenance of remission with human recombinant interferon alfa-2a in patients with stages III and IV low-grade malignant non-Hodgkin's lymphoma. European Organization for Research and Treatment of Cancer Lymphoma Cooperative Group. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 19980127.